Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Stichting Julius Research is a Dutch foundation that serves as the parent organization for Julius Clinical, a specialized scientific Contract Research Organization (CRO). The organization is closely affiliated with the University Medical Center Utrecht (UMC Utrecht), bridging the gap between academic excellence and clinical trial operations. It provides comprehensive services for the design and management of Phase II through IV clinical trials, with a particular focus on large-scale global studies. The foundation's expertise is concentrated in therapeutic areas such as cardiovascular, metabolic, infectious, and respiratory diseases, as well as brain health. By leveraging a network of world-renowned scientific leaders, Stichting Julius Research ensures that clinical programs are scientifically robust and operationally efficient. Its unique model combines academic peer-to-peer interaction with professional trial management to support the pharmaceutical and biotechnology sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Stichting Julius Research.